EGFR and neoplasm: Despite only binding ∼10% EGFR on A431 cells the 111In-ch806 demonstrated a mean peak uptake at 3 days of 33%ID g−1 and was highly retained within the tumour over the study period, in marked contrast to 125I-ch806, which showed minimal specific A431 tumour uptake.